Clinical Trial Update: Bepanthen Versus Cetomacrogol in Epidermal Growth Factor Receptor Inhibitors (EGFRI) [Phase 3]

View source ↗

Summary

Phase 3 trial comparing Bepanthen against Cetomacrogol for EGFR inhibitor–related skin rash in cancer patients has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Bepanthen (dexpanthenol)
• Cetomacrogol (cetomacrogol)

Snippet

Sponsor: Impaqtt Foundation | Conditions: Cancer, Skin Rash | Phase 3 | Status: COMPLETED